Keywords: bioalliance, closes, million-euro, series, financing, pharma, sa
BioAlliance closes 12 million-euro Series C financing
Article | 06 September 2004
BioAlliance Pharma SA, a privately-held biopharmaceutical companyspecializing in drug resistance, has raised an extra 2.0 million euros ($2.4 million) to close its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
